3 ms·
Data point according to: https://fr.wikipedia.org/wiki/Industrie_pharmaceutique#Lobbying https://fr.wikipedia.org/wiki/Industrie_pharmaceutique#Lobby... In 20
by guerby 7y ago
Data point according to:
https://fr.wikipedia.org/wiki/Industrie_pharmaceutique#Lobbying https://fr.wikipedia.org/wiki/Industrie_pharmaceutique#Lobby...
In 2003 pharma industry was pending more than 20 000 EUR per year per doctor in France. Not far for a full time employee per doctor.
One quarter of revenue on marketing, more than for research.
Most of this is because of government granted monopolies aka patents.
Alternatives are proposed, see Dean Baker for example
https://www.nytimes.com/roomfordebate/2015/09/23/should-the-government-impose-drug-price-controls/end-patent-monopolies-on-drugs https://www.nytimes.com/roomfordebate/2015/09/23/should-the-...
http://cepr.net/publications/briefings/testimony/drugs-are-cheap-why-do-we-let-governments-make-them-expensive http://cepr.net/publications/briefings/testimony/drugs-are-c...
https://www.ncbi.nlm.nih.gov/pubmed/15346683 https://www.ncbi.nlm.nih.gov/pubmed/15346683
(yes nothing new :)
Book : https://deanbaker.net/books/rigged.htm https://deanbaker.net/books/rigged.htm
Blog : http://cepr.net/blogs/beat-the-press/ http://cepr.net/blogs/beat-the-press/
- rscho 7y agoI very much doubt it's 20'000 EUR for GPs. It's likely much lower, because what you are citing includes data for surgeons, dermatologists, ophtalmologists, etc. who all are much higher priority targets for pharma marketing.
- friedman23 7y ago>One quarter of revenue on marketing, more than for research. They wouldn't be spending money on marketing if those expenses didn't bring in more dollars. Which in turn means more money for research...